Neon drop · Free ship $75+ · Enter the grid
Login Register
Signal · Product Feed
TMP269 - Class IIa HDAC Inhibitor. CAS# 1314890-29-3 size:10mg solid Significant rates of apoptosis are
TMP269 - Class IIa HDAC Inhibitor. CAS# 1314890-29-3 size:10mg solid Significant rates of apoptosis are
TMP269 - Class IIa HDAC Inhibitor. CAS# 1314890-29-3 size:10mg solid Significant rates of apoptosis are
TMP269 - Class IIa HDAC Inhibitor. CAS# 1314890-29-3 size:10mg solid Significant rates of apoptosis are

TMP269 - Class IIa HDAC Inhibitor. CAS# 1314890-29-3 size:10mg solid Significant rates of apoptosis are

SKU: 67135364337

4.4
USD120.00 USD159.00

Pay in 4 interest-free payments of $30.00 Learn more

Shipping Estimate
USA
  • USA
  • CAN

Ships within 48 hours · Estimated delivery Aug 5 - Aug 10

Live Spec

TMP269 - Class IIa HDAC Inhibitor. CAS# 1314890-29-3 size:10mg solid Significant rates of apoptosis areTMP269, CAS No. 1314890 29 3, is a highly potent, selective and cell permeable class IIa HDAC inhibitor with IC50 of 126 nM, 80 nM, 36 nM and 19 nM for HDAC4, HDAC5, HDAC7 and HDAC9 respectively. It has very weak or no activity targeting the other HDACs (2 40 M). TMP269 has an unprecedented metal binding group, trifluoromethyloxadiazole (TFMO), which circumvents the selectivity and pharmacologic liabilities of hydroxamates. Crystallography revealed a

Store: lifelines-uk.org.uk · Domain: lifelines-uk.org.uk

Description

Significant rates of apoptosis are seen in all models that had been treated with combination GSK2256098 and Paclitaxel

10(10):e0139850

is a widely used

which is responsible for the degradation of atrial and brain natriuretic peptide

TMP269 - Class IIa HDAC Inhibitor. CAS# 1314890-29-3 size:10mg solid Significant rates of apoptosis areTMP269, CAS No. 1314890 29 3, is a highly potent, selective and cell permeable class IIa HDAC inhibitor with IC50 of 126 nM, 80 nM, 36 nM and 19 nM for HDAC4, HDAC5, HDAC7 and HDAC9 respectively. It has very weak or no activity targeting the other HDACs (2 40 M). TMP269 has an unprecedented metal binding group, trifluoromethyloxadiazole (TFMO), which circumvents the selectivity and pharmacologic liabilities of hydroxamates. Crystallography revealed a

Exchange/Return Notes
  • We offer a 30-day return/exchange service after receiving.
  • Final sale items are not eligible for returns or exchanges.
  • To process your return/exchange, please contact us at [email protected]
  • Please click here for more details>>> Return & Exchange Policy

You may also like

recommand products